DexCom (DXCM) PT Lowered to $90 at BMO Capital Following 2Q on 'Near-Term Medicare Reimbursement Disruption'

August 2, 2017 9:49 AM

BMO Capital lowered its price target on DexCom (NASDAQ: DXCM) to $90.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found